This topic contains a solution. Click here to go to the answer

Author Question: If the information necessary to calculate corrected count increment (CCI) or post-transfusion ... (Read 58 times)

fbq8i

  • Hero Member
  • *****
  • Posts: 527
If the information necessary to calculate corrected count increment (CCI) or post-transfusion platelet recovery (PPR) is not available,
 
  a rough estimate of _________ increment per one unit of platelet concentrate transfused in an average adult patient can be used.
 
  a. 500/L
  b. 1,000/L
  c. 2,000/L
  d. 5,000/L

Question 2

Platelet refractoriness can be indicated by an immediate post-transfusion corrected count increment (CCI) of less than
 
  a. 5,000 on at least one occasion
  b. 5,000 on at least two occasions
  c. 7,500 on at least one occasion
  d. 7,500 on at least two occasions



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meow1234

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Answer: c

Answer to Question 2

Answer: b




fbq8i

  • Member
  • Posts: 527
Reply 2 on: Jun 25, 2018
:D TYSM


isabelt_18

  • Member
  • Posts: 342
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Although the Roman numeral for the number 4 has always been taught to have been "IV," according to historians, the ancient Romans probably used "IIII" most of the time. This is partially backed up by the fact that early grandfather clocks displayed IIII for the number 4 instead of IV. Early clockmakers apparently thought that the IIII balanced out the VIII (used for the number 8) on the clock face and that it just looked better.

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

For a complete list of videos, visit our video library